About the RELEASE Study
This clinical research study is looking at how safe a potential new medication (investigational medication) is and whether it improves depression for people with bipolar I disorder.
Why is this study important?
Although treatments are available for people with depression and bipolar I, they do not work for everyone, and some people experience undesirable side effects. It is important to look for potential treatment options that may work differently from available treatments.
What will this study involve?
If you take part, you will be in the RELEASE Study for up to 10 weeks (2.5 months). You will need to visit the study center 7 times and have 2 phone calls. You will be assigned, by chance, to receive either the investigational medication or placebo. The placebo looks like the investigational medication but contains no active ingredients.